Paris +

Florence Coussau has comprehensive experience in the counseling and litigation aspects of French labor and employment law. She assists Firm clients with restructurings, collective dismissals related to economic conditions, labor aspects of M&A (notably in the case of transfer of employees), reorganizations, working time issues, compliance issues related to codes of business conduct, whistleblowing policies and other internal policies, negotiation of senior executives' compensation and terminations, and employee representation.

Florence's experience includes representing employers in litigation related to collective dismissals implemented for economic reasons, employee representatives/trade union actions in the context of restructurings or employee representation, dismissal of senior executives for personal grounds, discrimination, and harassment of employees.

Florence assists the Firm's French and international clients acting in various industrial areas such as the aerospace and health business sectors or specialized new technologies such as internet software and biotech companies.


  • HOERBIGER Group acquires Deublin CompanyJones Day advised HOERBIGER Group, a privately-held industrial company headquartered in Switzerland, on the acquisition of Deublin Company, the leading manufacturer of rotating unions in the world.
  • Inotrem raises €39 million in Series B financing roundJones Day advised Inotrem S.A., a French biotech company specialized in immunotherapy for acute and chronic inflammatory syndromes, in connection with its €39 million (US$43 million) Series B round of financing led by Morningside Ventures and joined by Invus as well as historical investors including Andera Partners, Sofinnova Partners, and BiomedInvest.
  • Procter & Gamble acquires consumer health business of Merck KGaAJones Day advised The Procter & Gamble Company (“P&G”) in its €3.375 billion ($4.2 billion) acquisition of the worldwide consumer health business of Merck KGaA.
  • Brico Privé sold to Florac InvestissementsJones Day advised Brico Privé SAS, the leading French online flash sales platform dedicated to do-it-yourself (DIY), gardening and home-improvement, its management, and Ardian in connection with the leveraged buy-out of Brico Privé by Florac Investissements.
  • David Lloyd Leisure acquires The City Green Sports and Health ClubJones Day advised David Lloyd Leisure Ltd. in its announced acquisition of City Green Sport and Health Club. The deal is due to complete in early March 2018 and it will become the company’s 112th club.
  • Alizé Pharma SAS acquired by Millendo Therapeutics, Inc.Jones Day advised Alizé Pharma SAS, a French clinical-stage biotech private company, in connection with its sale in a stock-for-stock transaction to Millendo Therapeutics, Inc., a U.S. clinical-stage biotech private company focused on developing novel treatments for endocrine diseases.
  • A2Mac1 sold to Five Arrows Principal InvestmentsJones Day advised A2Mac1, a leading player in benchmarking data for the automotive industry, and the selling founders in connection with the leveraged buy-out by Five Arrows Principal Investments.
  • Chemical company harmonizes working conditions following acquisitionsJones Day advised a leading global supplier of technology-based functional coatings and color solutions following its acquisition of local companies on its framework for the regularization and harmonization of working conditions, employment contracts, and work rules.
  • European company restructures management, transactional, and collective dismissal procedureJones Day counseled a European subsidiary of global corporation on a variety of employment-related issues.
  • Verizon sells its cloud and managed hosting service to IBMJones Day advised Verizon Communications, Inc. in the sale of its cloud and managed hosting service to International Business Machines Corporation.
  • Chemical product manufacturing company creates new company in FranceJones Day assisted a chemical product manufacturing company with the creation of a new company in France following the acquisition of a business.
  • AccorHotels acquires AvailproJones Day advised AccorHotels, a French multinational hotel group, in connection with its acquisition of Availpro, a leading European software provider to hoteliers.
  • International company negotiates collective bargaining agreements after transfer of assets involving several facilitiesJones Day advised an international company on negotiating various company-wide collective agreements.
  • Reverse sale of Genticel to GenKyoTex SA to become GenkyotexJones Day advised Genticel SA in connection with its reverse sale to the shareholders of GenKyoTex who received approximately 80 percent of the share capital of Genticel in remuneration of their contribution of GenKyoTex shares to Genticel.
  • International cloud-based spend management provider navigates organization of professional elections and reduction in workforceJones Day assisted international cloud-based spend management provider with the organization of professional elections and reduction of its workforce.
  • Wabtec acquires Faiveley Transport for $1.8 billionJones Day advised Wabtec Corporation in the acquisition of Faiveley Transport S.A., a global supplier of high added value integrated systems for the railway industry, for a total of $1.8 billion in cash and stock, including assumed debt.
  • Calgon Carbon acquires Arkema's activated carbon and filtration media business for €145.5 million (US$160.1 million)Jones Day advised Calgon Carbon Corporation in the €145.5 million (US$160.1 million) acquisition of the wood-based activated carbon, reactivation, and mineral-based filtration media business of CECA, a subsidiary of Arkema, a French leading specialty chemicals and advanced materials company.
  • Wellington Partners, Bpifrance, CITA Investissement, CEA Investissement, and b-to-v Partners invest in UroMemsJones Day advised Wellington Partners, Bpifrance, CITA Investissement, CEA Investissement, and b-to-v Partners AG in connection with a €12 million ($12.7 million) private placement in UroMems, an innovative medtech company developing an active medical implantable device for treatment of urinary incontinence.
  • Medical technology company closes French subsidiary's activitiesJones Day assisted a medical technology company with the closing of its subsidiary's activities in France.
  • Talend completes IPO of American Depositary Shares on NASDAQJones Day represented Talend SA, a software vendor specializing in big data and cloud integration solutions, in connection with its issuance of $94.5 million of American Depositary Shares in an initial public offering on NASDAQ.
  • We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.